Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's OCF Margin % or its related term are showing as below:
HKSE:06922'
s OCF Margin % Range Over the Past 10 Years
Min: -377.72 Med: -256.41 Max: -6.11
Current: -6.62
During the past 6 years, the highest OCF Margin % of Cryofocus Medtech (Shanghai) Co was -6.11%. The lowest was -377.72%. And the median was -256.41%.
HKSE:06922's OCF Margin % is ranked worse than 68.6% of 812
companies
in the Medical Devices & Instruments industry
Industry Median: 6.645
vs HKSE:06922: -6.62
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryofocus Medtech (Shanghai) Co OCF Margin % Chart
HKSE:06922 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryofocus Medtech (Shanghai) Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryofocus Medtech (Shanghai) Co (HKSE:06922) has a OCF Margin % of 2.35% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cryofocus Medtech (Shanghai) Co and its competitors. According to the industry distribution chart, Cryofocus Medtech (Shanghai) Co ranks #557 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 68.6%.
Is Cryofocus Medtech (Shanghai) Co's OCF Margin % too high?
Cryofocus Medtech (Shanghai) Co's current OCF Margin % is 2.35%. The Medical Devices & Instruments industry median OCF Margin % is 6.65. Cryofocus Medtech (Shanghai) Co's value of 2.35% is 64.6% below this industry median. Based on the distribution chart, Cryofocus Medtech (Shanghai) Co ranks #557 out of 812 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Cryofocus Medtech (Shanghai) Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryofocus Medtech (Shanghai) Co's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cryofocus Medtech (Shanghai) Co ranks #557 out of 812 companies for OCF Margin %. This places Cryofocus Medtech (Shanghai) Co in the lower half of its industry. The industry median OCF Margin % is 6.65. Cryofocus Medtech (Shanghai) Co's value of 2.35% is 64.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.65, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cryofocus Medtech (Shanghai) Co's current OCF Margin % of 2.35% is 64.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cryofocus Medtech (Shanghai) Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cryofocus Medtech (Shanghai) Co's current OCF Margin % is 2.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryofocus Medtech (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Cryofocus Medtech (Shanghai) Co (HKSE:06922) is currently considered Possible Value Trap. The stock's GF Value™ is HK$21.01, compared to a current price of HK$2.79 — trading 86.7% below its estimated fair value. The current OCF Margin % is 2.35% and 64.6% below the Medical Devices & Instruments industry median of 6.65. Cryofocus Medtech (Shanghai) Co's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Cryofocus Medtech (Shanghai) Co (HKSE:06922), the current OCF Margin % is 2.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cryofocus Medtech (Shanghai) Co (HKSE:06922) Overvalued in 2026?
Based on GuruFocus' analysis, Cryofocus Medtech (Shanghai) Co stock appears to be undervalued.
The current stock price of HK$2.79 is trading 86.7% below its estimated GF Value™ of HK$21.01.
GuruFocus considers Cryofocus Medtech (Shanghai) Co to be Possible Value Trap.
Key valuation signals for HKSE:06922:
OCF Margin %: 2.35%
GF Value™: HK$21.01 vs. price of HK$2.79 (86.7% below fair value)
Industry Position: 64.6% below the Medical Devices & Instruments median (#557 of 812)
No single metric tells the full story. See the HKSE:06922 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products. The company uses liquid nitrogen as the main cryogenic source for cryotherapy systems by leveraging liquid nitrogen cryoablation technology and flexible catheter technology. The products offered by the company include: Bladder Cryoablation System, Pulmonary Nodule Localization Needle, and Endoscopic Clip for Anastomosis, among others. Geographically, the company's revenue is generated from the sale of medical consumables and devices in the Chinese Mainland.
61GF Score
Get the complete analysis for HKSE:06922
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06922 has been successfully added to your 
